content top

EVRS Award Lecture given by Dr. Richard Spaide, USA

Improving the Age-Related Macular Degeneration Construct: A New Classification System Previous models of disease in age-related macular degeneration (AMD) were incomplete in that they did not encompass subretinal drusenoid deposits (pseudodrusen), subtypes of neovascularization, and polypoidal choroidal vasculopathy. In addition, Type 3 neovascularization starts in the retina and may not necessarily involve the choroid. As such the term...

Read More

Intravitreal Bevacizumab (Avastin) Treatment of Choroidal Neovascularization Secondary to Age-related Macular Degeneration

http://www.evrs.eu/medias/2006/congress/Intravitreal-Bevacizumab-(Avastin)-Treatment-of-Choroidal-Neovascularization-Secondary-to-Age-related-Macular-Degeneration.swf Richard F. Spaide, MD (New York, NY),* Ketan Laud, MD (New York, NY), Howard Fine, MD (New York, NY), James M. Klancnik, MD (New York, NY), Catherine Meyerle, MD (New York, NY), Lawrence Yannuzzi, MD (New York, NY), John Alan Sorenson, MD (New York, NY), Jason S. Slakter, MD...

Read More

Outcomes of 77 Consecutive Cases of 23-gauge Sutureless Transconjunctival Surgery for Posterior Segment Disease

Howard F. Fine, MD (New York, NY), Richard F. Spaide, MD (New York, NY), Reza Iranmanesh, MD (New York, NY), Diana Iturralde, MD (Pamplona, Spain) PURPOSE: Twenty-five gauge vitrectomy systems possess several advantages over 20-g methods including improved wound healing, conjunctival sparing, and patient comfort. Newer 23-g systems were introduced to improve instrument bore size and rigidity while retaining sutureless technique. The...

Read More
content top